newsfilter
← Latest News
Business Wire·

CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates

Believes Integration Will Bring Enhanced Efficiency and Simplicity to the Company's Structure Notes the Company Will Fold Centurion into CytRx Dr. Louis Ignarro, Chairman of the Compensation Committee, to Retire from the Board as of the July 2022